Drugs / cordyceps sinesis capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07174076 | Jul 2025 → Jul 2028 expected | Mycobacterium avium complex disease | Bin Cao | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cordyceps sinesis capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07174076 ↗ |
| Known as | Bailiing Capsule | “cordyceps sinesis capsule (Bailiing Capsule)” NCT07174076 ↗ |
| Route | Oral | “cordyceps sinesis capsule 4 capsules tid po for 12 months” NCT07174076 ↗ |